Consainsights logo

Vascular Stent Market Size, Share, Industry Trends and Forecast to 2030

Vascular Stent Market Research Report – Segmented By Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2030.


  • Published date -30th Jan 2024

  • Formats -PDF, CSV

  • Region -Global

Vascular Stent Market Size & CAGR

The Vascular Stent market size is projected to reach USD 8.5 billion in 2023 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.2% from 2023 to 2030.

COVID-19 Impact on the Vascular Stent Market

The COVID-19 pandemic has significantly impacted the Vascular Stent market, causing disruptions in the supply chain and affecting the demand for medical devices. Healthcare facilities faced challenges in providing elective procedures, leading to a temporary decline in the adoption of vascular stents. However, the market is expected to rebound as healthcare services resume and the emphasis on cardiovascular health increases.

Vascular Stent Market Dynamics

Driver: Technological Advancements

The Vascular Stent market is driven by technological advancements in stent design, materials, and deployment techniques. Innovations such as drug-eluting stents and bioresorbable stents have improved treatment outcomes and patient safety, leading to increased adoption of vascular stents in cardiovascular procedures.

Restraint: Regulatory Challenges

Regulatory challenges related to the approval and reimbursement of vascular stents pose a restraint to market growth. Stringent regulations and pricing pressures in healthcare systems impact the market dynamics, requiring manufacturers to navigate complex approval processes and pricing negotiations.

Opportunity: Growing Aging Population

The increasing prevalence of cardiovascular diseases among the aging population presents a significant opportunity for the Vascular Stent market. As the global population ages, the demand for minimally invasive cardiovascular interventions, including stent placements, is expected to rise, driving market growth.

Challenge: Competition from Alternative Therapies

The Vascular Stent market faces competition from alternative therapies such as medication, lifestyle modifications, and surgical interventions. Patients and healthcare providers weigh the benefits and risks of different treatment options, impacting the adoption of vascular stents in clinical practice.

Segments and Related Analysis of the Vascular Stent Market

The Vascular Stent market is segmented by product type, material, end-user, and region. Drug-eluting stents, bare-metal stents, and bioresorbable stents are key product segments, while metal, polymer, and biodegradable materials are commonly used in stent manufacturing. Hospitals, ambulatory surgical centers, and specialty clinics are major end-users of vascular stents. Regional analysis reveals variations in market dynamics, regulatory environments, and healthcare infrastructure impacting market growth.

Vascular Stent Market Analysis Report by Region

Asia Pacific Vascular Stent Market Report

The Asia Pacific region is witnessing a significant increase in cardiovascular diseases, driving the demand for vascular stents. Improving healthcare infrastructure, rising disposable incomes, and a growing aging population contribute to market growth in countries like China, India, and Japan.

South America Vascular Stent Market Report

South America presents opportunities for market expansion due to the increasing prevalence of cardiovascular diseases and the adoption of advanced medical technologies. Brazil, Argentina, and Colombia are key markets for vascular stents in the region.

North America Vascular Stent Market Report

North America dominates the Vascular Stent market, driven by high healthcare expenditure, advanced medical facilities, and favorable reimbursement policies. The United States and Canada are major consumers of vascular stents, with a focus on innovation and quality of care.

Europe Vascular Stent Market Report

Europe is a key market for vascular stents, characterized by a well-established healthcare system, research infrastructure, and regulatory framework. Countries like Germany, France, and the United Kingdom drive market growth through investments in cardiovascular health and medical technology.

Middle East and Africa Vascular Stent Market Report

The Middle East and Africa region exhibit opportunities for Vascular Stent market growth, supported by increasing awareness of cardiovascular health, expanding healthcare facilities, and government initiatives to improve healthcare access. Countries like Saudi Arabia, UAE, and South Africa are key markets in the region.

Vascular Stent Market Analysis Report by Technology

The Vascular Stent market embraces various technologies, including drug-eluting stents, bioresorbable stents, and bare-metal stents, each offering unique benefits and applications in cardiovascular interventions. Advancements in stent design, coating materials, and deployment methods enhance procedural outcomes and patient safety, shaping the market landscape.

Vascular Stent Market Analysis Report by Product

Vascular stents are available in different product categories, such as coronary stents, peripheral stents, and neurovascular stents, catering to specific clinical needs and anatomical considerations. Manufacturers develop specialized stents for coronary artery disease, peripheral arterial disease, and cerebral aneurysms, providing clinicians with a range of options for optimal patient care.

Vascular Stent Market Analysis Report by Application

Vascular stents find applications in various cardiovascular procedures, including percutaneous coronary intervention (PCI), carotid artery stenting, and iliac artery angioplasty. The versatility of stents in treating coronary, peripheral, and neurovascular conditions highlights their importance in modern interventional cardiology and vascular surgery practices.

Vascular Stent Market Analysis Report by End-User

Hospitals, ambulatory surgical centers, and specialty clinics are primary end-users of vascular stents, where clinicians perform diagnostic and interventional procedures for cardiovascular diseases. The adoption of stents in different healthcare settings reflects the diverse patient populations, clinical practices, and procedural requirements across the continuum of care.

Key Growth Drivers and Key Market Players of Vascular Stent Market

The Vascular Stent market is driven by factors such as increasing prevalence of cardiovascular diseases, growing aging population, technological advancements in stent design, and rising demand for minimally invasive interventions. Key market players in the Vascular Stent market include:

  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Terumo Corporation

Vascular Stent Market Trends and Future Forecast

The Vascular Stent market is witnessing trends such as the development of bioresorbable stents, personalized medicine approaches in stent selection, and expansion of indications for stent use. Future forecasts suggest continued growth in demand for vascular stents, driven by technological innovations, clinical research, and healthcare infrastructure investments.

Recent Happenings in the Vascular Stent Market

  • Medtronic launched a new drug-eluting stent for coronary artery disease treatment.
  • Abbott Laboratories acquired a leading manufacturer of neurovascular stents.
  • Boston Scientific Corporation introduced a next-generation peripheral stent system for arterial revascularization.
  • C. R. Bard, Inc. received FDA approval for its innovative bioresorbable vascular scaffold.
  • Terumo Corporation partnered with a research institute to develop novel stent coating technologies.

Related Industries

    Vascular Stent Market FAQs

    1. What is the market size of the Vascular Stent?

    The global vascular stent market size was valued at $8.2 billion in 2020 and is projected to reach $11.4 billion by 2027, with a CAGR of 4.6% during the forecast period.

    2. What are the key market players or companies in the Vascular Stent industry?

    Some of the key market players in the vascular stent industry include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, C. R. Bard, Inc., Terumo Corporation, and Biotronik SE & Co. KG.

    3. What are the primary factors driving the growth in the Vascular Stent industry?

    The primary factors driving the growth in the vascular stent industry include the increasing prevalence of cardiovascular diseases, technological advancements in stent design and materials, growing demand for minimally invasive procedures, and a rise in the aging population globally.

    4. Which region is identified as the fastest-growing in the Vascular Stent?

    The Asia-Pacific region is identified as the fastest-growing in the vascular stent market due to the increasing healthcare expenditure, rising adoption of advanced medical technologies, and growing prevalence of cardiovascular diseases in countries like China and India.

    5. Does ConsaInsights provide customized market report data for the Vascular Stent industry?

    Yes, ConsaInsights provides customized market report data for the vascular stent industry tailored to specific client requirements, including market size, trends, competitive landscape, and growth opportunities.

    6. What deliverables can I expect from this Vascular Stent market research report?

    From this vascular stent market research report, you can expect detailed analysis of market trends, market size and forecasts, competitive landscape, key market players, technological advancements, regulatory landscape, and growth opportunities in the industry.